LINC02202

Across TCGA pan-cancer cohorts, LINC02202 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated LINC02202 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC02202 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02202 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

UVM, KIRP, and HNSC are the cancer types where LINC02202 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	III,IV	0.337	0.756	<.001	76	view →
KIRP	OS	Tertile	All	0.581	0.839	<.001	70	view →
HNSC	DFS	Quartile	All	0.504	0.242	.009	39	view →
UCS	OS	Median	All	0.726	0.412	.003	36	view →
KIRC	OS	Tertile	All	0.903	0.835	.002	35	view →
STAD	DFS	Tertile	All	0.479	0.637	.006	31	view →
PAAD	OS	Quartile	All	0.605	0.359	.010	19	view →
BLCA	DFS	Median	IV	0.103	0.334	.012	15	view →
LIHC	OS	Tertile	II,III,IV	0.711	0.268	.003	14	view →
THCA	DFS	Median	All	0.934	0.861	.002	13	view →
GBM	OS	Median	All	0.428	0.234	.016	12	view →
OV	DFS	Median	IV	0.366	0.551	.029	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

LINC02202–UVM (DFS)

Open the UVM breakdown →